This case-based program will focus on elucidating the role of nitric oxide in eyes with glaucoma, providing strategies to achieve target intraocular pressure levels with newer topical agents that home in on the trabecular meshwork, and interpreting clinically relevant data supporting the efficacy and safety of these new agents.

This educational activity will help optometrists better understand the influences of nitric oxide on the trabecular meshwork and to integrate new therapy based on safety and efficacy in preventing glaucoma progression.

This educational activity will review clinical data on an emerging treatment for blepharoptosis to help eyecare practitioners better identify, diagnose and treat appropriate patients who would benefit from pharmacologic treatment of blepharoptosis.

In this interprofessional webcast, experts in optometric and neurologic assessment and treatment of neuromyelitis spectrum disorder (NMOSD) discuss best practices in diagnosis and referral of patients with possible NMOSD as well as clinical data supporting 3 newly approved long-term suppressive treatments specifically targeting immunologic pathways altered by NMOSD autoantibodies.